Skip to main content

Advertisement

SpringerLink
Log in

Neuromyelitis optica and pregnancy

  • Review Article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Neuromyelitis optica (NMO) and the associated NMO spectrum disorders are demyelinating disorders affecting the spinal cord and optic nerves. It has prominent female predominance and many of these patients are in their childbearing years. As pregnancy seems to have a major impact on this disease course, in this review, recent studies with a focus on this disease and pregnancy and safety of available treatment options during this period are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wingerchuk DM et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805–815

    Article  CAS  PubMed  Google Scholar 

  2. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG, International Panel for NMO Diagnosis (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lennon VA et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106–2112

    Article  CAS  PubMed  Google Scholar 

  4. Kim W, Kim S-H, Kim HJ (2011) New insights into neuromyelitis optica. J Clin Neurol 7(3):115–127

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kim W et al (2012) Influence of pregnancy on neuromyelitis optica spectrum disorder. Neurology 78(16):1264–1267

    Article  CAS  PubMed  Google Scholar 

  6. Jacob A, Elsone L, Fujihara K, de Seze J et al (2013) Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry 84(8):922–930

    Article  PubMed  Google Scholar 

  7. Papadopoulos MC, Verkman A (2012) Aquaporin 4 and neuromyelitis optica. Lancet Neurol 11(6):535–544

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wingerchuk DM (2009) Neuromyelitis optica: effect of gender. J Neurol Sci 286(1):18–23

    Article  CAS  PubMed  Google Scholar 

  9. Wingerchuk DM et al (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53(5):1107

    Article  CAS  PubMed  Google Scholar 

  10. Wingerchuk DM, Weinshenker BG (2003) Neuromyelitis optica clinical predictors of a relapsing course and survival. Neurology 60(5):848–853

    Article  PubMed  Google Scholar 

  11. Saadoun S et al (2013) Neuromyelitis optica IgG causes placental inflammation and fetal death. J Immunol 191(6):2999–3005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Vukusic S, Marignier R (2015) Multiple sclerosis and pregnancy in the ‘treatment era’. Nat Rev Neurol 11(5):280–289

  13. Fragoso YD et al (2013) Neuromyelitis optica and pregnancy. J Neurol 260(10):2614–2619

    Article  PubMed  Google Scholar 

  14. Asgari N et al (2014) Pregnancy outcomes in a woman with neuromyelitis optica. Neurology 83(17):1576–1577

    Article  PubMed  Google Scholar 

  15. Igel C et al (2015) Neuromyelitis optica in pregnancy complicated by posterior reversible encephalopathy syndrome, eclampsia and fetal death. J Clin Med Res 7(3):193

    Article  PubMed  Google Scholar 

  16. Bourre B et al (2012) Neuromyelitis optica and pregnancy. Neurology 78(12):875–879

    Article  CAS  PubMed  Google Scholar 

  17. Shimizu Y et al. (2015) Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder. Mult Scler. doi:10.1177/1352458515583376

  18. Wegmann TG et al (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a T H 2 phenomenon? Immunol Today 14(7):353–356

    Article  CAS  PubMed  Google Scholar 

  19. Orsi N, Tribe R (2008) Cytokine networks and the regulation of uterine function in pregnancy and parturition. J Neuroendocrinol 20(4):462–469

    Article  CAS  PubMed  Google Scholar 

  20. Dwosh E et al (2003) The interaction of MS and pregnancy: a critical review. Int MS J 10(2):38–43

    CAS  PubMed  Google Scholar 

  21. De Falco M et al (2007) Down-regulation of aquaporin 4 in human placenta throughout pregnancy. In Vivo 21(5):813–817

    PubMed  Google Scholar 

  22. Chen Y et al (2014) The complement and immunoglobulin levels in NMO patients. Neurol Sci 35(2):215–220

    Article  CAS  PubMed  Google Scholar 

  23. Thoroddsen A et al (2011) The water permeability channels aquaporins 1–4 are differentially expressed in granulosa and theca cells of the preovulatory follicle during precise stages of human ovulation. J Clin Endocrinol Metab 96(4):1021–1028

    Article  CAS  PubMed  Google Scholar 

  24. Kim SO et al (2011) Expression of aquaporin water channels in the vagina in premenopausal women. J Sex Med 8(7):1925–1930

    Article  CAS  PubMed  Google Scholar 

  25. Nour MM, Nakashima I, Coutinho E, Woodhall M, Sousa F, Revis J, Takai Y, George J, Kitley J, Santos ME, Nour JM, Cheng F, Kuroda H, Misu T, Martins-da-Silva A, DeLuca GC, Vincent A, Palace J, Waters P, Fujihara K, Leite MI (2016) Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder. Neurology 86(1):79–87

    Article  CAS  PubMed  Google Scholar 

  26. Palace J, Leite I, Jacob A (2012) A practical guide to the treatment of neuromyelitis optica. Pract Neurol 12(4):209–214

    Article  PubMed  Google Scholar 

  27. Briggs GG, Freeman RK, Yaffe SJ (2012) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 9th edn. Lippincott Williams, Wilkins

  28. Benediktsson R et al (1997) Placental 11β-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol 46(2):161–166

    Article  CAS  Google Scholar 

  29. Carmichael SL et al (2007) Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 197(6):585.e1–585.e7

    Article  CAS  Google Scholar 

  30. Park-Wyllie L et al (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62(6):385–392

    Article  CAS  PubMed  Google Scholar 

  31. Laskin CA et al (1997) Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 337(3):148–154

    Article  CAS  PubMed  Google Scholar 

  32. Norwood F et al (2013) Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2013-305572

    Google Scholar 

  33. Sau A et al (2007) Azathioprine and breastfeeding—is it safe? BJOG Int J Obstet Gynaecol 114(4):498–501

    Article  CAS  Google Scholar 

  34. Østensen M et al (2010) Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology. doi:10.1093/rheumatology/keq350

    PubMed  Google Scholar 

  35. Francella A et al (2003) The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 124(1):9–17

    Article  CAS  PubMed  Google Scholar 

  36. Hou S (2003) Pregnancy in renal transplant recipients. Adv Ren Replace Ther 10(1):40–47

    Article  PubMed  Google Scholar 

  37. Bermas BL (2014) Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy. Curr Opin Rheumatol 26(3):334–340

    Article  CAS  PubMed  Google Scholar 

  38. Sifontis NM et al (2006) Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82(12):1698–1702

    Article  CAS  PubMed  Google Scholar 

  39. Kimbrough DJ et al (2012) Treatment of neuromyelitis optica: review and recommendations. Mult Scler Relat Disord 1(4):180–187

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Perez-Aytes A et al (2008) In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am J Med Genet Part A 146(1):1–7

    Article  Google Scholar 

  41. Minagar A, Sheremata WA (2000) Treatment of Devic’s disease with methotrexate and prednisone. Int J MS Care 2(4):43–49

    Article  Google Scholar 

  42. Sahraian M et al (2010) Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients. Eur J Neurol 17(6):794–799

    Article  CAS  PubMed  Google Scholar 

  43. Bichuetti DB et al (2010) Neuromyelitis optica treatment: analysis of 36 patients. Arch Neurol 67(9):1131–1136

    Article  PubMed  Google Scholar 

  44. McKeon A et al (2008) CNS aquaporin-4 autoimmunity in children. Neurology 71(2):93–100

    Article  CAS  PubMed  Google Scholar 

  45. Bakker J, Metz L (2004) Devic’s neuromyelitis optica treated with intravenous gamma globulin (IVIG). Can J Neurol Sci Le journal canadien des sciences neurologiques 31(2):265–267

    Article  Google Scholar 

  46. Okada K, Tsuji S, Tanaka K (2007) Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica. Intern Med 46(19):1671–1672

    Article  PubMed  Google Scholar 

  47. Ateka-Barrutia O, Nelson-Piercy C (2012) Management of rheumatologic diseases in pregnancy. Int J Clin Rheumatol 7(5):541–558

    Article  CAS  Google Scholar 

  48. Friedman DM et al (2010) Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 62(4):1138–1146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Nguyen T, Alraqum E, Ahmed AR (2015) Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis. Int Immunopharmacol 26(1):1–3

    Article  CAS  PubMed  Google Scholar 

  50. Erkurt MA et al (2014) A life-saving therapy in Class I HELLP syndrome: therapeutic plasma exchange. Transfus Apher Sci 52(2):194–198

  51. Kronbichler A et al (2015) Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review. Autoimmun Rev 15(1):38–49

  52. Golay J et al (2000) Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood 95(12):3900–3908

    CAS  PubMed  Google Scholar 

  53. Grillo-López AJ et al (1999) Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma. Semin Oncol 26(5 Suppl 14):66–73

  54. Klink D et al (2008) Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol 2008(1):1

    Article  Google Scholar 

  55. Lee EJ et al (2014) Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth. Obstet Gynecol Sci 57(6):526–529

    Article  PubMed  PubMed Central  Google Scholar 

  56. Friedrichs B et al (2006) The effects of rituximab treatment during pregnancy on a neonate. Haematologica 91(10):1426–1427

    PubMed  Google Scholar 

  57. Decker M et al (2006) Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 7(8):693–694

    Article  PubMed  Google Scholar 

  58. Ojeda-Uribe M et al (2013) Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases. Clin Rheumatol 32(5):695–700

    Article  PubMed  Google Scholar 

  59. Ponte P, Lopes MJP (2010) Apparent safe use of single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy. J Am Acad Dermatol 63(2):355–356

    Article  PubMed  Google Scholar 

  60. Kimby E, Sverrisdottir A, Elinder G (2004) Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 72(4):292–295

    Article  PubMed  Google Scholar 

  61. Pham T et al (2008) Rituximab (MabThera) therapy and safety management. Clinical tool guide developed by the Rheumatic Diseases & Inflammation Group (Club Rhumatismes et Inflammation, CRI) of the French Society for Rheumatology (Société Française de Rhumatologie, SFR). Joint Bone Spine 75:S2–S99

    Article  Google Scholar 

  62. Ringelstein M et al (2013) Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum. Mult Scler J 19(11):1544–1547

    Article  CAS  Google Scholar 

  63. Hosseini H et al (2003) Neuromyelitis optica after a spinal anaesthesia with bupivacaine. Mult Scler 9(5):526–528

    Article  CAS  PubMed  Google Scholar 

  64. Facco E, Giorgetti R, Zanette G (2010) Spinal anaesthesia and neuromyelitis optica: cause or coincidence? Eur J Anaesthesiol (EJA) 27(6):578–580

    Article  Google Scholar 

  65. Gunaydin B, Akcali D, Alkan M (2001) Epidural anaesthesia for caesarean section in a patient with Devic’s syndrome. Anaesthesia 56(6):565–567

    Article  CAS  PubMed  Google Scholar 

  66. Sadana N, Houtchens M, Farber M (2012) Anesthetic management of a parturient with neuromyelitis optica. Int J Obstet Anesth 21(4):371–375

    Article  CAS  PubMed  Google Scholar 

  67. Uzawa A et al (2009) Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis. J Neurol Sci 287(1):105–107

    Article  CAS  PubMed  Google Scholar 

  68. Kay CS et al (2008) NMO–IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy. J Neurol Sci 275(1):148–150

    Article  PubMed  Google Scholar 

  69. Nakamura M et al (2007) Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands. Mul Scler 13(3):332–335

    Article  CAS  Google Scholar 

  70. Kister I et al (2006) Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 63(6):851–856

    Article  PubMed  Google Scholar 

  71. Furukawa Y et al (2006) Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population. Eur J Neurol 13(6):655–658

    Article  CAS  PubMed  Google Scholar 

  72. Zifman E et al (2010) Marked hypotonia in an infant of a mother with Devic disease. J Child Neurol 25(6):746–747

    Article  PubMed  Google Scholar 

  73. Lucchinetti CF et al (2002) A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 125(7):1450–1461

    Article  PubMed  Google Scholar 

  74. Bonnet F et al (1999) Devic’s neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus 8(3):244–247

    Article  CAS  PubMed  Google Scholar 

  75. Bencherifa F et al (2007) Devic’s neuro-optic myelitis and pregnancy. J Fr Ophtalmol 30(7):737–743

    Article  CAS  PubMed  Google Scholar 

  76. Pellkofer H et al (2009) Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Mult Scler 15(8):1006–1008

    Article  CAS  PubMed  Google Scholar 

  77. Cornelio DB et al (2009) Devic’s neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential. Arch Gynecol Obstet 280(3):475–477

    Article  PubMed  Google Scholar 

  78. Tsugawa J et al (2010) [A case of anti-aquaporin 4 antibody-positive Sjogren syndrome associated with a relapsed myelitis in pregnancy]. Rinsho shinkeigaku Clin Neurol 50(1):27–30

    Article  Google Scholar 

  79. Shang W, Liu J (2011) Neuromyelitis optica during pregnancy. Int J Gynecol Obstet 115(1):66–68

    Article  Google Scholar 

  80. Yaguchi H et al (2012) Pathological study of subacute autoimmune encephalopathy with anti-AQP4 antibodies in a pregnant woman. Mult Scler J 18(5):683–687

    Article  Google Scholar 

  81. Jurewicz A, Selmaj K (2015) Relapse of neuromyelitis optica during pregnancy—treatment options and literature review. Clin Neurol Neurosurg 130:159–161

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, MS Research Center, Neuroscience Institute, Sina Hospital, Tehran University of Medical Science, Imam Khomeini Ave., Hasan Abad Sq., Tehran, Iran

    Ameneh Zare-Shahabadi, Hamidreza Ghalyanchi Langroodi, Amir Reza Azimi & Mohammad Ali Sahraian

  2. Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Ameneh Zare-Shahabadi

  3. Iranian Center of Neurological Researches, Imam Khomeini Hospital, Tehran University of Medical Science, Keshavarz Blvd., Tehran, Iran

    Mohammad Hossein Harirchian

  4. Neurology Department, Booalisina Hospital, Mazandaran University of Medical Science, Pasdaran Boulevard, Sari, Iran

    Seyed Mohammad Baghbanian

Authors
  1. Ameneh Zare-Shahabadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hamidreza Ghalyanchi Langroodi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amir Reza Azimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammad Ali Sahraian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammad Hossein Harirchian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seyed Mohammad Baghbanian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seyed Mohammad Baghbanian.

Ethics declarations

Conflict of interest

Authors have no conflict of interest to declare.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zare-Shahabadi, A., Langroodi, H.G., Azimi, A.R. et al. Neuromyelitis optica and pregnancy. Acta Neurol Belg 116, 431–438 (2016). https://doi.org/10.1007/s13760-016-0654-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-016-0654-x

Keywords

Search

Navigation